$8.57
-0.09 (-1.04%)
Market Cap
$73.9M
Shares Outstanding
8,537,286
Institutional Holders
47
Total Inst. Value
$13.9M
% of Float Held
66.6%
QoQ Holder Change
—
Institutional data as of Q1 2025
Top 10 Institutional Holders(Q1 2025)
| # | Fund | Value | Shares |
|---|---|---|---|
| 1 | VANGUARD GROUP INC | $1.9M | 510,294 |
| 2 | ADAGE CAPITAL PARTNERS GP, L.L.C. | $1.6M | 421,322 |
| 3 | Exome Asset Management LLC | $1.5M | 2,000,000 |
| 4 | Eversept Partners, LP | $962K | 257,154 |
| 5 | BlackRock, Inc. | $908K | 242,742 |
| 6 | CITADEL ADVISORS LLC | $774K | 206,909 |
| 7 | JPMORGAN CHASE & CO | $638K | 170,790 |
| 8 | Catalio Capital Management, LP | $582K | 155,622 |
| 9 | T. Rowe Price Investment Management, Inc. | $523K | 139,646 |
| 10 | Avidity Partners Management LP | $503K | 134,566 |
Famous Fund Managers
Related Stocks
Frequently Asked Questions
How many institutional investors hold KPTI?
As of Q1 2025, 47 institutional investors report holding KPTI (Karyopharm Therapeutics Inc.) in their 13F filings.
What percentage of Karyopharm Therapeutics Inc. is owned by institutions?
Institutional investors hold approximately 66.6% of Karyopharm Therapeutics Inc.'s float as reported in SEC 13F filings.
Which hedge fund owns the most KPTI?
The largest institutional holder of KPTI is VANGUARD GROUP INC with $1.9M in shares.
Are institutions buying or selling KPTI?
This quarter, 47 institutions opened new positions in KPTI and 1 closed their positions.
What is 13F institutional ownership?
SEC Form 13F is a quarterly report filed by institutional investment managers with over $100M in qualifying assets. It discloses their US equity holdings, providing transparency into what the largest investors are buying and selling.
How often is institutional ownership data updated?
13F filings are due 45 days after each calendar quarter end (May 15, Aug 14, Nov 14, Feb 14). Data is updated on HedgeTrace as new filings are processed.